Insider Transactions
| Date | Name | Title | Filing | Type | Shares Traded | Price Range | Total Held |
|---|---|---|---|---|---|---|---|
| Aug 17, 2012 | SVP, GM - Vascular | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 7,500 | -- | 27,500 | |
| Jan 03, 2006 | Director, President & CEO | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 7,500 | $4.35 | 21,289 | |
| Jan 03, 2006 | Director, President & CEO | Form 4 | Open market or private sale of non-derivative or derivative security | 7,500 | $25.02 | 13,789 | |
| Jan 03, 2006 | Director, President & CEO | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 7,500 | -- | 250,682 | |
| Dec 14, 2005 | Director, President & CEO | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 7,500 | $4.35 | 21,289 | |
| Dec 14, 2005 | Director, President & CEO | Form 4 | Open market or private sale of non-derivative or derivative security | 7,500 | $25.01 | 13,789 | |
| Dec 14, 2005 | Director, President & CEO | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 7,500 | -- | 258,182 | |
| Dec 01, 2005 | Director, President & CEO | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 7,500 | $4.35 | 21,289 | |
| Dec 01, 2005 | Director, President & CEO | Form 4 | Open market or private sale of non-derivative or derivative security | 7,500 | $20.62 | 13,789 | |
| Dec 01, 2005 | Director, President & CEO | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 7,500 | -- | 265,682 |
For recent transactions, including derivative transactions, see our Section 16 SEC filings page.